Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation
RR Razonable, RT Hayden - Clinical microbiology reviews, 2013 - Am Soc Microbiol
The negative impact of cytomegalovirus (CMV) infection on transplant outcomes warrants
efforts toward improving its prevention, diagnosis, and treatment. During the last 2 decades …
efforts toward improving its prevention, diagnosis, and treatment. During the last 2 decades …
Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration
M Kueckelhaus, S Fischer, M Seyda… - Transplant …, 2016 - Wiley Online Library
The advent of more potent immunosuppressants led to the first successful human upper
extremity transplantation in 1998. At this time,> 100 upper extremity transplants, 30 face …
extremity transplantation in 1998. At this time,> 100 upper extremity transplants, 30 face …
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …
The international registry on hand and composite tissue transplantation
P Petruzzo, M Lanzetta, JM Dubernard, L Landin… - …, 2010 - journals.lww.com
Background. The International Registry on Hand and Composite Tissue Transplantation was
founded in May 2002, and the analysis of all cases with follow-up information up to July …
founded in May 2002, and the analysis of all cases with follow-up information up to July …
Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study
Background The risk to benefit ratio of face transplantation with a composite tissue allograft
remains debatable, although this procedure is technically feasible. We report here a 1-year …
remains debatable, although this procedure is technically feasible. We report here a 1-year …
Human facial allotransplantation: a 2-year follow-up study
S Guo, Y Han, X Zhang, B Lu, C Yi, H Zhang, X Ma… - The Lancet, 2008 - thelancet.com
Background Progress in composite tissue allotransplantation could provide a new treatment
for patients with severe facial disfigurements. We did a partial facial allotransplantation in …
for patients with severe facial disfigurements. We did a partial facial allotransplantation in …
[HTML][HTML] Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes
Composite tissue allotransplantations can be indicated when autologous transfers fail to
restore human appearance. We report the reproducibility, difficulties, serious adverse events …
restore human appearance. We report the reproducibility, difficulties, serious adverse events …
The international registry on hand and composite tissue transplantation
P Petruzzo, M Lanzetta, JM Dubernard… - …, 2008 - journals.lww.com
Background. Since May 2002, all groups performing hand transplantations have supplied
information to the International Registry on Hand and Composite Tissue Transplantation …
information to the International Registry on Hand and Composite Tissue Transplantation …
Composite tissue allotransplantation: opportunities and challenges
J Iske, Y Nian, R Maenosono, M Maurer… - Cellular & molecular …, 2019 - nature.com
Vascularized composite allotransplants (VCAs) have unique properties because of diverse
tissue components transplanted en mass as a single unit. In addition to surgery, this type of …
tissue components transplanted en mass as a single unit. In addition to surgery, this type of …
World experience after more than a decade of clinical hand transplantation: update on the Innsbruck program
T Hautz, TO Engelhardt, A Weissenbacher… - Hand …, 2011 - hand.theclinics.com
Hand Clin 27 (2011) 423–431 doi: 10.1016/j. hcl. 2011.07. 004 0749-0712/11/$–see front
matter© 2011 Elsevier Inc. All rights reserved. hand. theclinics. com combination with …
matter© 2011 Elsevier Inc. All rights reserved. hand. theclinics. com combination with …